Paul Govern Archive — Page 43 of 54
-
June 4, 2015
Precision medicine efforts highlighted at NIH workshop
Affirmation of Vanderbilt University Medical Center’s high profile in precision medicine came last week when a new working group convened by the National Institutes of Health (NIH) visited Vanderbilt for a two-day public workshop devoted to planning a key component of the federal Precision Medicine Initiative announced earlier this year by President Obama. -
May 28, 2015
Awards recognize commitment to service excellence
Credo Award and Five Pillar Leader Award winners were announced May 21 at the Vanderbilt University Medical Center Clinical Enterprise Leadership Assembly at Langford Auditorium. These staff and faculty awards are given on a quarterly basis. -
May 28, 2015
Clinical Enterprise Leadership Assembly explores changing health care economy
The Vanderbilt University Medical Center Spring Clinical Enterprise Leadership Assembly, held on May 21 at Langford Auditorium, highlighted ways the Medical Center is preparing to lead in a consumer-driven health care economy, where patients’ concerns over both cost and quality will drive industry change. -
May 28, 2015
New colorectal surgery protocol reduces length of hospital stay by 25 percent
For colorectal surgery patients at Vanderbilt University Medical Center, the introduction last summer of a new patient care protocol, which includes intensive follow-up by anesthesiologists in the hospital, has led to an average 25 percent reduction in hospital length of stay after surgery — from four days to three — and 90 percent reduction in the use of opioids to treat post-operative pain. -
May 21, 2015
Grant helps expand training outreach program in Kenya
In an especially underserved region of western Kenya, expectant mothers requiring cesarean section are the focus of a new $2.6 million grant to Vanderbilt University Medical Center (VUMC), Kenya’s AIC Kijabe Hospital and the Kenya-based Center for Public Health and Development. -
May 21, 2015
Study to explore optimal daily aspirin dose for heart health
The Vanderbilt-based Mid-South Clinical Data Research Network (CDRN) is among seven CDRNs that will collaboratively mount a three-year, $14 million randomized clinical trial to determine the best daily dose of aspirin for preventing heart attacks and strokes among people living with heart disease.